# Biomark Diagnostics Inc. — Form D

Biomark Diagnostics Inc. of RICHMOND, A1, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-14. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-04-14
- Form: D
- Accession: 0002064257-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 10
- Date of first sale: 2025-03-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-543611

## Issuer

- Name: Biomark Diagnostics Inc.
- CIK: 0002064257
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 130 - 3851 SHELL RD, RICHMOND, A1, V6X 2W2
- Phone: 604-370-0779

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Rashid Bux | Director | Richmond, A1 |
| Brian Kai-Ming Cheng | Director | Richmond, A1 |
| Bramhanand Ramjiawan | Director | Richmond, A1 |
| Rashid Bux | Executive Officer | Richmond, A1 |
| Guoyu Kai-Ming Huang | Executive Officer | Richmond, A1 |

## More

- [CIK 2064257 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2064257&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002064257-25-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.